Zeitschriftenartikel (129)
51.
Zeitschriftenartikel
19 (8), S. 453 - 454 (2023)
AI and protein structure and function in neurological disease: relevance to disease management. Nature Reviews Neurology 52.
Zeitschriftenartikel
38 (7), S. 1127 - 1142 (2023)
Defining the riddle in order to solve it: There is more than one "Parkinson's Disease". Movement Disorders 53.
Zeitschriftenartikel
123 (14), S. 9094 - 9138 (2023)
Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 54.
Zeitschriftenartikel
13 (4), S. 633 - 636 (2023)
People with early onset Parkinson’s disease: empowered to improve care. Journal of Parkinson's Disease: JPD 55.
Zeitschriftenartikel
29 (33), e202300649 (2023)
Chemical Synthesis of Alpha-Synuclein Proteins via Solid-Phase Peptide Synthesis and Native Chemical Ligation. Chemistry – A European Journal 56.
Zeitschriftenartikel
14, 1918 (2023)
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications 57.
Zeitschriftenartikel
13 (2), S. 179 - 196 (2023)
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease: JPD 58.
Zeitschriftenartikel
23, 174 (2023)
Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 59.
Zeitschriftenartikel
177, 105995 (2023)
The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 60.
Zeitschriftenartikel
11 (8), 2209 (2023)
Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis. Biomedicines 61.
Zeitschriftenartikel
11 (2), 505 (2023)
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines 62.
Zeitschriftenartikel
38 (2), S. 162 - 177 (2022)
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 63.
Zeitschriftenartikel
12, S. 2397 - 2422 (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 64.
Zeitschriftenartikel
11 (22), 3673 (2022)
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 65.
Zeitschriftenartikel
269, 104721 (2022)
Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 66.
Zeitschriftenartikel
Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)
67.
Zeitschriftenartikel
10 (1), 98 (2022)
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 68.
Zeitschriftenartikel
168, 105696 (2022)
Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 69.
Zeitschriftenartikel
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 70.
Zeitschriftenartikel
87, S. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 71.
Zeitschriftenartikel
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
72.
Zeitschriftenartikel
404, S. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 73.
Zeitschriftenartikel
116 (51), S. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 74.
Zeitschriftenartikel
28, S. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 75.
Zeitschriftenartikel
47, S. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 76.
Zeitschriftenartikel
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 77.
Zeitschriftenartikel
47 (3), S. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 78.
Zeitschriftenartikel
85 (5), S. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 79.
Zeitschriftenartikel
12, 107 (2019)
Spreading of α-synuclein and tau: a systematic comparison of the mechanisms involved. Frontiers in Molecular Neuroscience 80.
Zeitschriftenartikel
22, 101135 (2019)
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology 81.
Zeitschriftenartikel
47, S. 197 - 207 (2019)
The role of LRRK2 in cell signalling. Biochemical Society Transactions 82.
Zeitschriftenartikel
33 (2), S. 2116 - 2131 (2019)
Monitoring α-synuclein multimerization in vivo. The FASEB Journal 83.
Zeitschriftenartikel
14, 5 (2019)
Dementia with Lewy bodies: an update and outlook. Molecular neurodegeneration 84.
Zeitschriftenartikel
27 (1), S. 79 - 91 (2019)
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorganic & Medicinal Chemistry 85.
Zeitschriftenartikel
28 (1), S. 31 - 50 (2019)
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Human Molecular Genetics 86.
Zeitschriftenartikel
18 (8), foy108 (2018)
Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast. FEMS Yeast Research 87.
Zeitschriftenartikel
33 (11), S. 1675 - 1684 (2018)
Sensing α-Synuclein from the outside via the prion problem: implications for neurodegeneration. Movement Disorders 88.
Zeitschriftenartikel
55, S. 8754 - 8763 (2018)
Diabetes mellitus as a risk factor for Parkinson's disease: a molecular point of view. Molecular Neurobiology 89.
Zeitschriftenartikel
38, S. 1539 - 1550 (2018)
Secretion and uptake of α-synuclein via extracellular vesicles in cultured cells. Cellular and Molecular Neurobiology 90.
Zeitschriftenartikel
18 (6), foy066 (2018)
The trehalose protective mechanism during thermal stress in Saccharomyces cerevisiae: the roles of Ath1 and Agt1. FEMS Yeast Research 91.
Zeitschriftenartikel
6, 79 (2018)
Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathologica Communications 92.
Zeitschriftenartikel
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry, 10.1038/s41380-018-0110-9 (2018)
93.
Zeitschriftenartikel
8, 6965 (2018)
(Poly)phenol-digested metabolites modulate alpha-synuclein toxicity by regulating proteostasis. Scientific Reports 94.
Zeitschriftenartikel
114 (5), S. 1036 - 1045 (2018)
Binding modes of phthalocyanines of amyloid β peptide and their effects on amyloid fibril formation. Biophysical Journal 95.
Zeitschriftenartikel
Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study. World journal of biological psychiatry, 10.1080/15622975.2017.1417636 (2018)
96.
Zeitschriftenartikel
37 (1), S. 139 - 159 (2018)
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy. EMBO Journal 97.
Zeitschriftenartikel
55, S. 5269 - 5281 (2018)
Implications of fALS mutations on Sod1 function and oligomerization in cell models. Molecular Neurobiology 98.
Zeitschriftenartikel
5 (1), S. 4 - 31 (2018)
Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell 99.
Zeitschriftenartikel
8 (1), S. 33 - 43 (2018)
Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson's disease. Journal of Parkinson's Disease: JPD 100.
Zeitschriftenartikel
119, S. 121 - 135 (2018)
Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. Neurobiology of Disease